Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...
Broadwater: With glaucoma, our two goals for controlling pressure are either slowing down fluid production or finding an ...
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...
Please provide your email address to receive an email when new articles are posted on . Glaucoma can be a difficult management problem in a subset of patients, even for the most experienced glaucoma ...
Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...
Glaucoma can be an unpredictable disease that responds differently to treatment options from patient to patient. Despite having several treatment and surgical options available, none of these are ...
SAVANNAH, GA (WTOC) - New technology means people with certain eye conditions may no longer have to go under the knife. One Savannah doctor says the new procedures for Glaucoma have many more benefits ...
Glaucoma is a group of conditions that affect the functioning of the optic nerve, the nerve bundle that connects the eye to the brain. The most common form of glaucoma involves increased pressure ...
ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...
5h
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
"We are thrilled to partner with Iridex to bring their cutting-edge retina laser technology to our members," said Phil Meyer, COO of EyeProGPO, LLC. "This partnership reflects our strong commitment to ...
LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced the company has acquired the IP and assets of MLase AG’s excimer ophthalmic laser system for glaucoma surgery. MLase manufactures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results